35986841_10216840653711318_1105697261150535680_n

GFP whole cell microbial biosensors : (Record no. 4269)

MARC details
000 -LEADER
fixed length control field 03633cam a2200421 a 4500
001 - CONTROL NUMBER
control field 17863137
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20180625093959.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130823s2013 nyua b 000 0 eng c
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2012277650
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780791860090
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0791860094
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1606504274
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781606504277
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)ocn828888913
040 ## - CATALOGING SOURCE
Original cataloging agency BTCTA
Language of cataloging eng
Transcribing agency BTCTA
Modifying agency EYM
-- OCLCO
-- ORE
-- UMC
-- YDXCP
-- DLC
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number TP248.27.M53
Item number G46 2013
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 660.62
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Delvigne, Frank.
245 00 - TITLE STATEMENT
Title GFP whole cell microbial biosensors :
Remainder of title scale-up and scale-down effects on biopharmaceutical processes /
Statement of responsibility, etc Frank Delvigne ... [et al.].
246 3# - VARYING FORM OF TITLE
Title proper/short title Green fluorescent protein whole cell microbial biosensors :
Remainder of title scale-up and scale-down effects on biopharmaceutical processes
250 ## - EDITION STATEMENT
Edition statement 1st ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc New York, N.Y. :
Name of publisher, distributor, etc ASME Press :
-- Momentum Press,
Date of publication, distribution, etc 2013.
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS
Date of production, publication, distribution, manufacture 2013
300 ## - PHYSICAL DESCRIPTION
Extent 43 p. :
Other physical details ill. (some col.) ;
Dimensions 24 cm.
490 1# - SERIES STATEMENT
Series statement Biomedical & nanomedical technologies - concise monograph series
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references (p. [36]-43).
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Interaction between fluid flow and microbial cells : importance of the operating scale -- Stochastic simulation of the displacement of microbial cells along concentration field -- Experimental results gained from the physiological response of GFP biosensors in scale-down conditions -- Another source of information : protein leakage and the study of the secretome.
520 3# - SUMMARY, ETC.
Summary, etc Two strategies are usually considered for the optimization of microbial bioprocesses. The first one involves genetic or metabolic engineering of the target microbial strains in order to improve its production efficiency or its tolerance to adverse conditions. The second one is based on the chemical engineering improvement of the bioreactors and scaling-up rules. This work is more particularly dedicated to this second class of parameters. Recent developments in bioreactor technologies follow the scaling-out principle, i.e. carrying out several cultures in parallel with controlled conditions for screening purposes. Several mini-bioreactor concepts, i.e. bioreactor with working volume of 1 to 100 mL with controlling devices, have been developed following this principle. In general, chemical engineering similarities between conventional stirred bioreactors and their miniature equivalent are well characterized. However, the actual scaling-up rules are not able to cope with the complexity of the microbial stress response. Indeed, microbial stress response still remains not completely understood considering the process perturbations and the environmental fluctuations accompanying the scaling-up to industrial bioreactors. At this time, this kind of response can only be experimentally predicted by using scale-down bioreactors, i.e. lab-scale bioreactors designed in order to reproduce mixing imperfections that have to be expected at large-scale. However, the use of such an approach is time consuming and requires an experimented staff to elaborate the scaling-down protocols. Indeed, bioprocess development involves several steps which cannot be necessarily linked with each other considering the different cultivation equipment used--
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Microbial biotechnology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Green fluorescent protein.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biosensors.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Delvigne, Frank.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Biomedical & nanomedical technologies.
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c pccadap
d 2
e ncip
f 20
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type Source of classification or shelving scheme
        Centeral Library Centeral Library Second Floor - Biotechnology 16.11.2016   660.62 D.F.G 2013 21413 16.11.2016 16.11.2016 Books  
        Centeral Library Centeral Library Second Floor - Biotechnology 07.12.2016   660.62 D.F.G 2013 21412 07.12.2016 07.12.2016 Books